CMS Star Ratings are here

CMS Star ratings show a record 17 of Prime’s Medicare contracts earning quality bonus payments

November 19, 2019
Prime Therapeutics (Prime) announced that a record 17 of its clients’ Medicare contracts earned a quality bonus payment. This is based on 2020 Star ratings recently released by the Centers for Medicare and Medicaid Services (CMS).

“The quality bonus payments will equate to hundreds of millions of dollars that our health plan clients will use to offer incremental benefits and/or reduce costs to their members,” says Ben Poehling, vice president, quality and performance programs. “This is another example of how Prime supports making health care more affordable for Medicare members across the country.”

Furthermore, 86 percent of Prime’s MAPD membership is in contracts that earned 4 or more Stars for the Part D rating.

Stars are made up of many elements

Dozens of individual measures roll up into a plan’s overall Star rating. Part C measures relate primarily to the health plan and medical benefit. Part D measures relate primarily to the drug benefit. As a pharmacy benefit manager, Prime influences many of the 13 Part D measures reflecting operations, customer experience and medication adherence. Prime also impacts a handful of the Part C measures.

“There is a lot of interaction between Part C and Part D measures,” explains Kim Kishel-Geiger, senior director, quality management. “The data-driven, partnering approach that Prime deploys with clients is showing results through improved ratings,” added Kim.

Challenged by continuous improvement

The star rating system is designed to continually improve the quality of care provided through Medicare. To do that, CMS evaluates performance data each year; they may adjust the cut points for metrics. This can make it difficult to earn higher Star ratings.

Prime programs like GuidedHealth, SmartAdherence and Quality Based Networks have helped improve adherence rates. These receive more weight than other metrics in determining ratings.

“The 4- and 5-Star cut points continue to be more and more challenging to achieve,” says Kim. Prime continually innovates, particularly in the areas of data and analytics, clinical programming and provider partnering, to stay ahead of the curve.”

“CMS had foresight when designing the Star rating system,” says Ben. “The agency rewards plans that deliver higher quality across both the medical and drug benefit. This is 100 percent aligned with our goal at Prime to lead the market in total drug management solutions that put people first.”

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion